MARKSANS PHARMA LTD. - Marksans Pharma Limited announces USFDA approval for Metformin Hydrochloride Extended-Release (ER) Tablets USP 500mg and 750mg (ANDA 090295)<BR>
02 May 2016
Marksans Pharma Ltd has informed BSE regarding a Press Release dated May 02, 2016, titled "Marksans Pharma Limited announces USFDA approval for Metformin Hydrochloride Extended-Release (ER) Tablets USP 500mg and 750mg (ANDA 090295)".
Source:
BSE India